NSUP
LEGN icon

NLB Skladi upravljanje premozenja’s Legend Biotech LEGN Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
50,000
+10,000
+25% +$270K 0.05% 206
2026
Q1 		$724K Buy
+40,000
New +$763K 0.03% 251

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

NLB Skladi upravljanje premozenja's LEGN Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja increased its Legend Biotech (LEGN) stake by 25% in Q2 2026, buying an estimated $270K and bringing the position to 50,000 shares worth $1.44M. The position accounts for 0.05% of the portfolio, ranked #206.

NLB Skladi upravljanje premozenja first reported a position in LEGN in Q1 2026 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 50,000 shares of Legend Biotech worth $1.44M as of Q2 2026.
  • NLB Skladi upravljanje premozenja bought 10,000 Legend Biotech shares in Q2 2026, an estimated $270K.
  • Legend Biotech made up 0.05% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #206 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Legend Biotech in Q1 2026 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.